These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8980395

  • 1. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds.
    Versantvoort CH, Rhodes T, Twentyman PR.
    Br J Cancer; 1996 Dec; 74(12):1949-54. PubMed ID: 8980395
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
    Twentyman PR, Rhodes T, Rayner S.
    Eur J Cancer; 1994 Dec; 30A(9):1360-9. PubMed ID: 7999426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
    Castro AF, Altenberg GA.
    Biochem Pharmacol; 1997 Jan 10; 53(1):89-93. PubMed ID: 8960067
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
    Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C, Huber H, Hofmann J.
    Br J Haematol; 1992 Sep 10; 82(1):161-8. PubMed ID: 1358171
    [Abstract] [Full Text] [Related]

  • 12. Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP).
    Manzano RG, Wright KA, Twentyman PR.
    Clin Cancer Res; 1996 Aug 10; 2(8):1321-6. PubMed ID: 9816303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells.
    Sedlák J, Hunáková L, Suliková M, Chorváth B.
    Leuk Res; 1997 May 10; 21(5):449-58. PubMed ID: 9225074
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE, Vellenga E.
    Clin Cancer Res; 2000 Aug 10; 6(8):3205-14. PubMed ID: 10955805
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I, Gekeler V, Ise W, Beck J, Spitaler M, Grunicke H, Hofmann J.
    Anticancer Res; 1996 Aug 10; 16(1):289-96. PubMed ID: 8615623
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.
    Limtrakul P, Khantamat O, Pintha K.
    J Chemother; 2005 Feb 10; 17(1):86-95. PubMed ID: 15828450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.